Jason Michael Nolan

Array ( [id] => 7801104 [patent_doc_number] => 08129374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Method of using imidazolothiazole compounds for the treatment of disease' [patent_app_type] => utility [patent_app_number] => 12/850557 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 40920 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129374.pdf [firstpage_image] =>[orig_patent_app_number] => 12850557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7727965 [patent_doc_number] => 20120012775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'ELECTROLYTE ADDITIVE OF DYE-SENSITIZED SOLAR CELL AND METHOD OF MAKING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/836628 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3694 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20120012775.pdf [firstpage_image] =>[orig_patent_app_number] => 12836628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137644 [patent_doc_number] => 20110009639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'SYNTHESIS OF ENONE INTERMEDIATE' [patent_app_type] => utility [patent_app_number] => 12/833628 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31555 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009639.pdf [firstpage_image] =>[orig_patent_app_number] => 12833628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097972 [patent_doc_number] => 20110003853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Metalloproteinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/830763 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37354 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003853.pdf [firstpage_image] =>[orig_patent_app_number] => 12830763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943495 [patent_doc_number] => 20110104115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE' [patent_app_type] => utility [patent_app_number] => 12/825237 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15434 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104115.pdf [firstpage_image] =>[orig_patent_app_number] => 12825237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097826 [patent_doc_number] => 20110003818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Substituted 2-Carboxamide Cycloamino Ureas' [patent_app_type] => utility [patent_app_number] => 12/824461 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24556 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003818.pdf [firstpage_image] =>[orig_patent_app_number] => 12824461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202899 [patent_doc_number] => 20110065685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'NOVEL INDOLES ARE CANNABINOID RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/815163 [patent_app_country] => US [patent_app_date] => 2010-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61145 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065685.pdf [firstpage_image] =>[orig_patent_app_number] => 12815163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442364 [patent_doc_number] => 07928092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Formulations and methods of treating inflammatory bowel disease' [patent_app_type] => utility [patent_app_number] => 12/797655 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18240 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928092.pdf [firstpage_image] =>[orig_patent_app_number] => 12797655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149995 [patent_doc_number] => 20110021590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'AMINOPYRROLIDINONE DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/795065 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 60557 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021590.pdf [firstpage_image] =>[orig_patent_app_number] => 12795065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144845 [patent_doc_number] => 20110130433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'Hepatitis C Virus Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/785665 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49804 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130433.pdf [firstpage_image] =>[orig_patent_app_number] => 12785665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6571607 [patent_doc_number] => 20100234591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'BIARYL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/767380 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57764 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234591.pdf [firstpage_image] =>[orig_patent_app_number] => 12767380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296209 [patent_doc_number] => 20100240611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'METHODS FOR PREPARING DPP-IV INHIBITOR COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/724775 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17787 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240611.pdf [firstpage_image] =>[orig_patent_app_number] => 12724775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6414033 [patent_doc_number] => 20100166881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Novel IDO Inhibitors and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/722099 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13730 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166881.pdf [firstpage_image] =>[orig_patent_app_number] => 12722099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6425030 [patent_doc_number] => 20100168106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase Modulation' [patent_app_type] => utility [patent_app_number] => 12/719606 [patent_app_country] => US [patent_app_date] => 2010-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45264 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168106.pdf [firstpage_image] =>[orig_patent_app_number] => 12719606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527472 [patent_doc_number] => 08044064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Fused pyrrolocarbazoles' [patent_app_type] => utility [patent_app_number] => 12/708306 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41797 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044064.pdf [firstpage_image] =>[orig_patent_app_number] => 12708306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569994 [patent_doc_number] => 20100234472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'NITRIC OXIDE RELEASING DERIVATIVES OF PARACETAMOL' [patent_app_type] => utility [patent_app_number] => 12/707410 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8253 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234472.pdf [firstpage_image] =>[orig_patent_app_number] => 12707410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432343 [patent_doc_number] => 07968589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 12/702358 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23373 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968589.pdf [firstpage_image] =>[orig_patent_app_number] => 12702358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289382 [patent_doc_number] => 20100158798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'FP-Pocket-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity' [patent_app_type] => utility [patent_app_number] => 12/701947 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17546 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158798.pdf [firstpage_image] =>[orig_patent_app_number] => 12701947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104049 [patent_doc_number] => 08153673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Metalloproteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/693852 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14817 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153673.pdf [firstpage_image] =>[orig_patent_app_number] => 12693852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388838 [patent_doc_number] => 20100317710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => '3-(3-INDOLYL) PROPIONIC ACID CALCIUM SALT AND METHOD OF MAKING 3-(3-INDOLYL) PROPIONIC ACID FREE ACID THEREFROM' [patent_app_type] => utility [patent_app_number] => 12/691067 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317710.pdf [firstpage_image] =>[orig_patent_app_number] => 12691067 [rel_patent_id] =>[rel_patent_doc_number] =>)